Clinical trial
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DOV 21,947 in Patients With Major Depressive Disorder
NCT00659347 is registered in ClinicalTrials.gov with DOV Pharmaceutical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DOV 21,947 in Patients With Major Depressive Disorder
- Lead sponsor
- DOV Pharmaceutical, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2008
- Completion date
- December 31, 2008
- Enrollment
- 200 (estimated)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.